Affiliation:
1. NanoBio Corporation, 2311 Green Road, Suite A, Ann Arbor, Michigan 48105
2. Fungal Testing Laboratory, University of Texas Health Science Center, San Antonio, Texas 78229
Abstract
ABSTRACT
NB-002 is an oil-in-water emulsion designed for use for the treatment of skin, hair, and nail infections. The activity of NB-002 was compared to the activities of the available antifungal drugs against the major dermatophytes responsible for cutaneous infections,
Trichophyton rubrum
,
Trichophyton mentagrophytes
,
Epidermophyton floccosum
, and
Microsporum
spp., as well as 12 other genera of filamentous fungi. NB-002 consistently displayed fungicidal activity against all dermatophytes. The comparator compounds were either fungistatic or fungicidal, and for some strain-drug combinations, tolerance was observed. Assessment of the development of spontaneous resistance to NB-002 in different dermatophyte species yielded few stably resistant mutants. For filamentous nondermatophyte fungi, the MIC range varied from 0.06 to 0.5 μg/ml for
Alternaria
spp. to 2 to 8 μg/ml for
Paecilomyes
spp. NB-002 had activity against both azole-susceptible and -resistant
Candida albicans
yeast isolates, with MIC
90
s of 2 μg/ml, respectively, and minimum fungicidal concentrations at which 90% of isolates are inhibited of 4 and 8 μg/ml, respectively. The kinetics of the fungicidal activity of NB-002 against
T. rubrum
isolates were compared to those of the other antifungal drugs. NB-002 killed both mycelia and microconidia even when the fungal forms were dormant or not actively growing. Electron micrographs of mycelia and spores treated with NB-002 showed the significant disruption of the fungal structure. The in vitro broad coverage of NB-002 against filamentous fungi, dermatophytes, and
C. albicans
, as well as its rapid fungicidal activity, warrants further investigations to ascertain if NB-002 would be useful for the treatment of cutaneous mycoses.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference53 articles.
1. Alley, M. R., S. J. Baker, K. R. Beutner, and J. Plattner. 2007. Recent progress on the topical therapy of onychomycosis. Expert Opin. Investig. Drugs16:157-167.
2. Anandan, V., V. Nayak, S. Sundaram, and P. Srikanth. 2008. An association of Alternaria alternata and Scopulariopsis brevicaulis in cutaneous phaeohyphomycosis. Indian J. Dermatol. Venereol. Leprol.74:244-247.
3. Asticcioli, S., A. Di Silverio, L. Sacco, I. Fusi, L. Vincenti, and E. Romero. 2008. Dermatophyte infections in patients attending a tertiary care hospital in northern Italy. New Microbiol.31:543-548.
4. Awadalla, F., D. A. Rosenbaum, F. Camacho, A. B. Fleischer, Jr., and S. R. Feldman. 2008. Dermatologic disease in family medicine. Fam. Med.40:507-511.
5. Abstr. 48th Intersci. Conf. Antimicrob. Agents Chemother. 2008
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献